A new study finds that high-flow nasal cannula oxygenation significantly reduces hypoxia in obese patients undergoing sedated gastrointestinal endoscopy, with a 2.0% incidence compared to 21.2% in standard oxygenation.
February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.